[go: up one dir, main page]

MX2010013310A - Derivados de heterociclil urea para el tratamiento de infecciones bacterianas. - Google Patents

Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.

Info

Publication number
MX2010013310A
MX2010013310A MX2010013310A MX2010013310A MX2010013310A MX 2010013310 A MX2010013310 A MX 2010013310A MX 2010013310 A MX2010013310 A MX 2010013310A MX 2010013310 A MX2010013310 A MX 2010013310A MX 2010013310 A MX2010013310 A MX 2010013310A
Authority
MX
Mexico
Prior art keywords
treatment
bacterial infections
urea derivatives
heterocyclic urea
heterocyclic
Prior art date
Application number
MX2010013310A
Other languages
English (en)
Inventor
Laura Choy Allison
Sherer Brian
Irvin Manchester John
Hill Pamela
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40823415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010013310(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MX2010013310A publication Critical patent/MX2010013310A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se describen compuestos de fórmula (I) y sus sales farmacéuticamente aceptables. También se describen procedimientos para su preparación, composiciones farmacéuticas que los contienen, su uso como medicamentos y su uso en el tratamiento de infecciones bacterianas. (ver fórmula).
MX2010013310A 2008-06-04 2009-06-03 Derivados de heterociclil urea para el tratamiento de infecciones bacterianas. MX2010013310A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5873608P 2008-06-04 2008-06-04
PCT/GB2009/050611 WO2009147433A1 (en) 2008-06-04 2009-06-03 Heterocyclic urea derivatives for the treatment of bacterial infections

Publications (1)

Publication Number Publication Date
MX2010013310A true MX2010013310A (es) 2011-03-01

Family

ID=40823415

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010013310A MX2010013310A (es) 2008-06-04 2009-06-03 Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.

Country Status (23)

Country Link
US (1) US8283361B2 (es)
EP (1) EP2300463A1 (es)
JP (1) JP2011522026A (es)
KR (1) KR20110014710A (es)
CN (1) CN102105469A (es)
AR (1) AR072045A1 (es)
AU (1) AU2009254930A1 (es)
BR (1) BRPI0915471A2 (es)
CA (1) CA2725568A1 (es)
CL (1) CL2009001349A1 (es)
CO (1) CO6382176A2 (es)
CR (1) CR11825A (es)
DO (1) DOP2010000373A (es)
EA (1) EA201001858A1 (es)
EC (1) ECSP10010664A (es)
IL (1) IL209503A0 (es)
MX (1) MX2010013310A (es)
PE (1) PE20100155A1 (es)
SV (1) SV2010003752A (es)
TW (1) TW201000475A (es)
UY (1) UY31864A (es)
WO (1) WO2009147433A1 (es)
ZA (1) ZA201008610B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1849465A4 (en) * 2005-02-18 2008-12-24 Takeda Pharmaceutical AGENS TO CONTROL THE FUNCTION OF THE GPR34 RECEPTOR
TW201102065A (en) * 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
WO2010142978A1 (en) * 2009-06-08 2010-12-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
CN102844305B (zh) 2010-03-31 2014-07-02 埃科特莱茵药品有限公司 抗菌异喹啉-3-基脲衍生物
AR088729A1 (es) 2011-03-29 2014-07-02 Actelion Pharmaceuticals Ltd Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法
WO2018048882A1 (en) 2016-09-06 2018-03-15 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
WO2018074880A2 (ko) * 2016-10-20 2018-04-26 한국화학연구원 퀴놀린 4-온 유도체 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 폐렴의 예방 또는 치료용 약학적 조성물
WO2018174288A1 (ja) 2017-03-24 2018-09-27 大正製薬株式会社 ２（１ｈ）－キノリノン誘導体
CN111808089B (zh) * 2019-04-10 2023-04-11 四川大学华西医院 一种治疗糖尿病的药物依格列净或其衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0589985A1 (en) 1991-06-21 1994-04-06 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
EP1341769B1 (en) 2000-12-15 2007-10-17 Vertex Pharmaceuticals Incorporated Bacterial gyrase inhibitors and uses thereof
AR042956A1 (es) 2003-01-31 2005-07-13 Vertex Pharma Inhibidores de girasa y usos de los mismos
US20080269214A1 (en) * 2005-03-04 2008-10-30 Astrazeneca Ab Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors
US8022816B2 (en) 2005-03-21 2011-09-20 Vela Systems, Inc. System and method for field management using radio frequency tags
US7569907B2 (en) 2005-03-28 2009-08-04 Cooper Technologies Company Hybrid chip fuse assembly having wire leads and fabrication method therefor
KR20070119032A (ko) 2005-04-13 2007-12-18 코닌클리케 필립스 일렉트로닉스 엔.브이. 위상 변조 이전에 워터마킹을 통한 인코딩
BRPI0620196A2 (pt) * 2005-12-23 2013-01-15 Astrazeneca Ab composto, processo para a preparaÇço do mesmo, composiÇço farmacÊutica, uso de um composto, e, mÉtodos para a produÇço de um efeito antibacteriano em um animal de sangue quente, para a inibiÇço de dna girase e/ou topoisomerase iv bacteriana em um animal de sangue quente e para o tratamento de uma infecÇço bacteriana em um animal de sangue quente
DE102006012337B3 (de) 2006-03-17 2007-11-29 Amphenol-Tuchel Electronics Gmbh Elektrischer Steckverbinder
RU2469034C2 (ru) * 2006-12-04 2012-12-10 Астразенека Аб Химические соединения
CN201038186Y (zh) 2007-03-08 2008-03-19 鹤山丽得电子实业有限公司 一种大功率led
TW200940537A (en) 2008-02-26 2009-10-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
WO2009110688A2 (ko) 2008-03-06 2009-09-11 Jang Gum Sik 태양광 발전 장치
WO2010142978A1 (en) * 2009-06-08 2010-12-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof

Also Published As

Publication number Publication date
SV2010003752A (es) 2011-04-14
CA2725568A1 (en) 2009-12-10
JP2011522026A (ja) 2011-07-28
WO2009147433A1 (en) 2009-12-10
US20100190745A1 (en) 2010-07-29
AR072045A1 (es) 2010-08-04
EA201001858A1 (ru) 2011-08-30
US8283361B2 (en) 2012-10-09
CN102105469A (zh) 2011-06-22
CL2009001349A1 (es) 2010-12-31
EP2300463A1 (en) 2011-03-30
TW201000475A (en) 2010-01-01
KR20110014710A (ko) 2011-02-11
IL209503A0 (en) 2011-01-31
PE20100155A1 (es) 2010-03-25
CR11825A (es) 2011-02-04
CO6382176A2 (es) 2012-02-15
ZA201008610B (en) 2012-08-29
AU2009254930A1 (en) 2009-12-10
ECSP10010664A (es) 2011-01-31
UY31864A (es) 2010-01-29
DOP2010000373A (es) 2011-01-15
BRPI0915471A2 (pt) 2017-06-27

Similar Documents

Publication Publication Date Title
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
UA96964C2 (ru) Соединения полициклической мочевины с антибактериальными свойствами
MX2007010072A (es) Derivados de piperidina antibacterianos.
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.
WO2010038081A3 (en) 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
MX2009011997A (es) Derivados de pirrolopirimidin-7-ona y su uso como farmaceuticos.
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
WO2010084115A3 (en) Antiviral agents
MX2009013501A (es) Compuestos piperidinicos y sus usos.
EA201001859A1 (ru) Гетероциклические производные мочевины и способы их применеия
MX2010006108A (es) Inhibidores de estearoil-coa-desaturasa.
WO2006092599A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
UY32856A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
MX2010009756A (es) Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos.
UY32694A (es) Derivados heterocíclicos de urea y métodos de uso de los mismos
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
WO2007071965A3 (en) Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
MX2011012384A (es) Derivados nitrilo y sus usos y composiciones farmaceuticas.
WO2006087544A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
WO2006087548A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
MX2012006287A (es) Activadores de azaindol glucocinasa.
MX2010008778A (es) Derivados de 3-alquil-piperazina y usos de la misma.
CU20100172A7 (es) Derivados heterocíclicos de urea y métodos de uso de los mismos-211
TW200626582A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal